Weidinger, S., A. Pink, J. Francisco, A. Kurbasic, C. Olsen, A. Vilsbøll, and M. de Bruin Weller. “Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients With Moderate-To-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s100, doi:10.25251/skin.4.supp.100.